Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The development of macrolides: clarithromycin in perspective.

H C Neu1

  • 1Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY.

The Journal of Antimicrobial Chemotherapy
|February 1, 1991
PubMed
Summary

Macrolide antibiotics, like erythromycin, are effective against various infections. Newer macrolides, such as clarithromycin, offer improved activity and tolerability for treating respiratory and other infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Postantibiotic effect of ceftibuten on respiratory pathogens.

The Pediatric infectious disease journal·1995
Same author

Ceftibuten: minimal inhibitory concentrations, postantibiotic effect and beta-lactamase stability--a rationale for dosing programs.

The Pediatric infectious disease journal·1995
Same author

In vitro activity of SCE-2787, a new cephalosporin with potent activity against Pseudomonas aeruginosa and members of the family Enterobacteriaceae.

Antimicrobial agents and chemotherapy·1994
Same author

Emerging trends in antimicrobial resistance in surgical infections. A review.

The European journal of surgery. Supplement. : = Acta chirurgica. Supplement·1994
Same author

Synergy and antagonism of fluoroquinolones with other classes of antimicrobial agents.

Drugs·1993
Same author

Gemfibrozil enhances the listeriacidal effects of fluoroquinolone antibiotics in J774 macrophages.

The Journal of experimental medicine·1992

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Microbiology

Background:

  • Macrolide antibiotics, originating from the Philippines, have been clinically used since 1952.
  • Erythromycin, a key macrolide, treats respiratory and cutaneous infections, especially in children.
  • Resurgent interest in macrolides is driven by pathogens like Legionella, Chlamydia, and Campylobacter.

Purpose of the Study:

  • To evaluate new 14-membered macrolides designed to improve upon older erythromycin agents.
  • To address limitations of erythromycin, including variable activity against Haemophilus influenzae, gastrointestinal irritation, and frequent dosing.
  • To highlight the therapeutic potential of clarithromycin for various infections.

Main Methods:

  • Synthesis of novel 14-membered macrolide compounds.
  • Assessment of antimicrobial activity against key pathogens, including Legionella, Chlamydia, Campylobacter, Haemophilus influenzae, and Streptococcus pneumoniae.
  • Evaluation of pharmacokinetic properties, such as plasma peak levels and half-life, and tolerability.

Main Results:

  • Clarithromycin demonstrates enhanced activity against Legionella, Branhamella spp., Pasteurella multocida, and anaerobic species.
  • Clarithromycin and its metabolite show inhibitory effects against Haemophilus spp. and increased activity against Chlamydia.
  • Clarithromycin offers improved pharmacokinetic profile (twice-daily dosing) and good tolerability compared to older macrolides.

Conclusions:

  • Clarithromycin represents a significant advancement in macrolide antibiotic therapy.
  • Its broad-spectrum activity, improved pharmacokinetics, and favorable tolerability profile make it suitable for respiratory, skin, diarrheal, and genital infections.
  • Clarithromycin offers a safe and effective alternative for treating infections caused by challenging pathogens.

Related Experiment Videos